New Enterprise Associates 16, L.P. Genocea Biosciences, Inc. (GNCA) insider trading activity

New Enterprise Associates 16, L.P. is > 10% Shareholder of GENOCEA BIOSCIENCES, INC.. Currently has a direct ownership of 0 shares of GNCA, which is worth approximately $0. The most recent transaction as insider was on May 25, 2022, when has been sold 4,445,093 shares (Common Stock) at a price of $0.08 per share, resulting in proceeds of $355,607. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

New Enterprise Associates 16, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 25 2022	SELL Open market or private sale	$355,607 $0.08 p/Share	4,445,093 Reduced 100.0%	0 Common Stock
May 24 2022	SELL Open market or private sale	$415,229 $0.07 p/Share	5,931,843 Reduced 57.16%	4,445,093 Common Stock

Also insider at

BHG

Bright Health Group Inc. Healthcare

MRKR

Marker Therapeutics, Inc. Healthcare

> 10% Shareholder

TRVI

Trevi Therapeutics, Inc. Healthcare

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

> 10% Shareholder

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

NEA